The slip
PARKINSON RECEIPTno. 11391
27 Oct 2026, 01:25 UTCdopamine neurons, braak
predictionDNAJC18 in dopamine neurons tracks Braak Lewy-body stage
registeredf20bb29a4b2d0244
discovery-0.59 p=0.092 n=9
replication+0.03 p=0.946 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.59, p 0.092)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTe922b28f7bfe1aa1921fccc8…
follows 5edea0765250…
Covered by the on-chain checkpoint of receipt 11398 (2026-10-27 01:35 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 11391: DNAJC18 in dopamine neurons, braak
- power
- full sample -0.19 (p 0.439, n 18), 95% CI -0.61 to +0.30. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.21 (p 0.398, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.17 (p 0.509, n 18). could be the mix.
- skeptic
- leave-one-out range -0.36 to -0.07, sign flips 0; without severely affected donors -0.19 (p 0.439, n 18). fragile.
- cell type
- strongest in oligodendrocytes: -0.70 (p 0.0011, n 18) vs -0.19 in dopamine neurons. proposing oligodendrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for DNAJC18 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up DNAJC18 · oligodendrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.40 p 0.155 (needs p < 1.9e-4)